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Abstract 
Background: Chlamydia trachomatis (C. trachomatis) is the most 
commonbacterialsexuallytransmittedinfection(STI).GenitalC.trachomatis 
infectionis leadingcause of complications e.g pelvic inflammatory infection 
(PID)tubal factor infertilityand abortion. 
Objectives: The objective of this study was to estimate the Frequency of 
Chlamydia trachomatis infection among symptomatic and asymptomaticwomen,by 
PCR-based assay. 
Methods:This was a cross-sectional study conducted over the periodfrom, May 
2012 to February 2013.A total of  240nonduplicateendocervical samples were 
taken frommarried womenEndocervical swabs were collected from women 
referred to Qazvin Kowsar GynecologyHospital by trainingmidwife.The specimens 
were tested for C trachomatisby PCR-based assay for phagene. 
 
 
 
Resu(1)lts: Out of 240 participants women 184 (76.7%) were symptomatic and 56 
(23.3%) were asymptomaticcases). The mean age of cases was 37.1±.0.9 
years.Twenty (8.3%) of 240 samples were diagnosed as Chlamydia positive 
according to PCR results.The prevalence of asymptomatic C. trachomatis 
infections was 6(10.7%), while14 (7.6%) symptomatic cases were 
infected.Thechi2test was not show a significant relationship between positive test 
result and vaginosis, abortion , infertility, premature birth, low birth weight below 
2.5kg 
 
Conclusion: The results of this study showed high prevalence of C. trachomatis 
infection among in both symptomatic and asymptomatic women. 
Therefore, a screening test for C.trachomatis infection is recommended for all 
women who refer to genitourinary medicine clinic.Screening programsare 
important for cost effectiveness calculations in complication of C. trachomatis 
infections especially in asymptomatic cases. 
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Introduction 
Chlamydiatrachomatis (C. trachomatis) is an obligateintra-cellular pathogen and 
the most frequent sexually transmitted bacterium worldwide(2-5) . While most of 
the infections occur without symptoms,asymptomatic manifestation of urogenital 
chlamydial infection can be observedin~30% of the patients.Ina subset of female 
patients,ascending genital tract infections caused disease such as 
salpingitis,pelvicinflammatorydisease (PID), or tubal infertility and abortion(6-10).  
C. trachomatis in the cervix could be transmitted to a neonate  during  passage 
through  an infected birth canal, resulting  in  neonatal pneumonia(11, 12). 
The gold standard for diagnosis of C. trachomatis infection has traditionally been a 
cultureof swab from the endocervix in women or the urethra in men (11). 
However, the methodological challenges of culturingof this organism and 
difficulty of thismethods led to the development of non-culture-based tests, 
including antigen-detection tests and nucleic acid hybridization.  These techniques 
however, fail to detect substantial proportion of infections. Newer tests are 
accordingly required to develop that could amplify and detect C. trachomatis- 
specific DNA or RNA sequences, giving rise to more sensitivity than the first 
generation non-culture-based tests(12-16).In many studies , target gene for NAATs 
were cryptic plasmid. Some studies give evidence or suggest that the plasmid-free 
 
 
 
variants are present in clinical samples. Thus, the infections caused by plasmid-free 
variants will be undetected if the plasmid is used as target gene (14) .   
 Targets for amplification have included both the cryptic plasmid (7, 8, 10, 18, 19, 
22-24, 27) andchromosomal genes, including those for the major outer membrane 
protein (MOMP) (2, 11, 23, 25, 33), gyrA, phospholipase D endonuclease 
superfamily gene (PRPHA). 
An object of this study  is to propose using  of unique sequences in the genome of 
C. trachomatis(17). 
 
 
 
 
Materials and Methods 
 
Study site and population:This was a cross-sectional study conducted over the 
period from, May 2012 to February 2013. During a 10- month- period, 
240endocervical samples were taken from married womenreferred to Qazvin 
Kowsar Gynecology Hospital. Endocervical swabs were collected from women 
referred to Qazvin Kowsar GynecologyHospital by trainingmidwife.The specimens 
were tested for C trachomatisby PCR-based assay for phagene. 
 
Sample collection Briefly, cervical mucus was removed prior to insertion 
of a Dacron swab into the endocervicl canalswab was immersed  in 1 ml 
ofphosphate buffered saline (PBS)transport medium. All PBS media were 
maintained at 4°C during specimen collection and  then  aliquoted into 
DNase and RNase free microtubes and frozenat -80°C within 4h of 
collection until DNA extraction(18). 
DNA Extraction: 
DNA was extracted from endocervical samples using  boilingtechnic and DNG 
PLUS . The concentration of DNA samples was determined as micrograms per 
milliliter based on A260 values and adjusted to 1 μl/ml prior to PCR amplification. 
 
Detection of C. trachomatis by PCR: 
PCR assay was performed for detection ofC. trachomatis by phagene .The primers 
wereF-(5´TCTTTTTAAACCTCCGGAACCCACTT 3´) 
R-(5´GGATGGCATCGCATAGCATTCTTTG3´) 
 
PCR amplificationwas performed in a final volume of 20 μlreaction 
mixture containing 1μl of each primers, 10 μl  master  mix sayber green 
(Bioneer),6 μl distilled water, 2 μl DNA samples. SequencedC. 
 
 
 
trachomatis DNA was used as positivecontrol and distilled water was used 
as negative control. 
DNA amplificationwas carried out with the following thermal cycling 
profile: for pha gene10min of initial denaturation at 95°C followed by 35 
cycles of amplification. Each cycle consisted of denaturationat 95°C for 15 
S, annealing at 60°C for 30 S, and extension at 72°C for 30  S. 
The PCR products were analyzed by 1.5% agarose gel electrophoresisand the 
product size estimated using a 100-bp DNA ladder. 
 
 
 
Statistical analyses: Data Statistical analyses were performedusing SPSS 
software (Statistical Package for the Social Sciences, V. 19.0; SPSS Inc, 
Chicago, IL, USA).Data were summarized by frequencies and percentages 
for categorical variables and normally distributed data, means and 
standarddeviation.Results were analyzed by chi-square tests. A level of P 
<0.05 was considered to indicate statistical significance. 
 
 
 
 
 
Results 
 
The study population was240 married women184 (76.7%) symptomatic 
and 56 (23.3%) asymptomatic cases).The mean age of  cases was 37.1±0.9 
years.In the period of this study,  
240marriedwomenenrolledinclding:18(7.5%) infertility, 
58(24.16%)abortion, vaginosis  126(52.5%)(sign and symptom include 
vaginal discharge vagina and irritation and dysuria), 13(5.4%) premature 
birth, 15(6.25%)  low birth weight below 2.5kg. Out of the 240 
endocerviclsoap samples weretested20 (8.3%)positive for 
Chlamydiatrachomatis by PCR .Of the 56 asymptomatic women, 6(10.7%) 
had chlamydia infection while among the 184symptomatic cases 14 
(7.6%) according to the PCR results. 
Among symptomatic women with Chlamydial infection;infrtilitywere0(%0), 
abortion were3(5.1%) ,vaginosiswere 9(7.1%)premature birth were 1(7.7%), low 
birth weight were1(7.7%). 
 
 
 
The chi2test  was not show a significant relationship between positive test result 
and vaginosis(P= 0.76), abortion (P= 0.55),  premature birth (P=1.0), low birth 
weight below 2.5kg (P=1.0) and  infertility (P= 0.36),   
 
 
 
 
Table 1: Frequency of chlamidial infection among married women according to symptoms  
Chracteristic PCR 
Positive 
n(%) 
PCR 
Negative 
n(%) 
Total 
 
n(%) 
P value 
Sympomatic     
Infertiltity 0(0%) 18(100%) 18(100%) 0.36 
Abortion 3(5.1%) 55(94.9%) 58(100%) 0.55 
Vaginosis 9(7.1%) 117(92.9%) 126(100%) 076 
Premature birth 1(7.7%) 12(92.3%) 13(100%) 1.0 
Low birth weight below 2.5kg 1(7.7%) 12(92.3%) 13(100%) 1.0 
Asympomatic     
Healthy women 6(10.7%) 50(89.3%) 56(100%)  
 
 
 
 
 
Figure 1-PCR amplification of C. trachomatis DNA Positive clinical sample,   1 kb plus 
DNAladder  L1L5Negativeclinical sample,L3, L6 control Positive, L2,L4Positiveclinical sample 
 
Discussion 
 
 
 
Chlamydia trachomatis is one of the most frequent causes of sexually transmitted 
diseases(2, 3). It is a common cause of urethritis and cervicitis. Some reported 
sequelae include PID, abortion,tubal factor infertility, epididymitis, proctitis and 
reactive arthritis (6-10) . 
The majority of chlamydia-infected individuals are asymptomatic, and remain 
unnoticed and untreated. Infected women may be at risk of gynaecological 
complications (e.g. PID and tubal infertility), and determine the reservoir for 
onward transmission in the population(19). 
 
 In the current study, the prevalence of chlamydialinfection among 240 women 
attendingKowsar GynecologyHospital in   Qazvin was8.3%.This ratein 
asymptomatic C. trachomatis infections caseswere 6(10.7%), while14 (7.6%) of 
symptomatic cases were infected. The chi2test  was not show a significant 
relationship between positive test result and vaginosis(P= 0.76), abortion (P= 
0.55),  premature birth (P=1.0), low birth weight below 2.5kg (P=1.0) and  
infertility (P= 0.36),   
 
Torrone et al, reportedthe prevalence of Chlamydia trachomatis genital infection 
among persons aged 14–39 years  in United States, during 2007–2012 was 1.7% . 
Overall prevalence of chlamydial infection among persons aged 14–39 years was 
similar over the three National Health and Nutrition Examination Survey 
(NHANES) cycles combined for this analysis: 2007–2008: 1.6% (CI = 1.1%–
2.2%); 2009–2010: 1.7% (CI = 1.2%–2.1%); and 2011–2012: 1.9% (CI = 1.5%–
2.2%). Chlamydia is the most commonly reported nationally notifiable disease, 
with over 1.4 million infections reported in 2012 . However, case reports likely 
underestimate the burden of disease because most infections are asymptomatic and 
are neither diagnosed nor reported. The 2007–2012 NHANES indicate that an 
estimated 1.8 million persons aged 14–39 years in the United States have a genital 
chlamydial infectionThese results showed that increasing chlamydial infection 
during 2007–2012 in USA(20). 
 
In a number of studies from other countries, showed the different rate of frequency 
of Chlamydia trachomatisendocervical infectionin women. 
Marconeet al,reported the prevalenceof C. trachomatis infection of women in 
Rome. The mean prevalance of C.trachomatisendocervical  infection during 2000 
to 2009 was 5.2%. The results of this study showed that the high rate ofsexually 
transmitted infections (STI)(21). 
 
Al-Thani et al,reported prevalence of C trachomatis infection among 377(37.9% 
Qataris, 62.1% non-Qataris) healthy women attending primary healthcare centers 
 
 
 
in Qatar. The specimens were tested for C trachomatis by PCR-based assay. 
Prevalence of C trachomatis infection was 5.3% among Qatari women and 5.5% 
among non-Qatari women. Similar to our study ,the high prevalence may reflect, in 
part, the limited access to and use of chlamydia screening and management(10). 
 
Araujo, R., et alincentral Brazilreportedthe overall prevalence of C. 
trachomatis infection by PCR was 19.6%(22).  
Cuffini et al,reported  prevalence of genital Chlamydia trachomatis Infection 
inAsymptomatic women in Argentine  was 13.7% (23). 
The results showed higher prevalence of C. trachomatis infection among  Latin 
American women than our study. 
conclusion:The present study shows that C.trachomatisendocervicalinfection 
could be present in symptomatic (7.6% ) as well as asymptomatic women (10.7%). 
The majority of chlamydia-infected individuals are asymptomatic, and remain 
unnoticed and untreated. Infected women may be at risk of gynaecological 
complications (e.g. PID and tubal infertility), and determine the reservoir for 
onward transmission in the population. Strategies for the control of infection and 
prevention of its complications are only partially effective (safer sex campaigns) or 
not yet available (vaccine). Screening programmes have been introduced as an 
additional strategy for early detection and treatment of infected cases. Cost-
effectiveness of screening is largely determined by the rates of complications 
prevented. Evidence on the impact of screening on the prevalence of chlamydia 
infections at a population level is still limited, as is the impact on the prevalence of 
complications in screened women. 
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